Nanomedicine against biofilm infections: A roadmap of challenges and limitations
WIREs Nanomedicine and Nanobiotechnology · 2024
DOI: 10.1002/wnan.1944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Núria Blanco-Cabra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bacterial Infections and Antimicrobial Therapy Group (BIAT), Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and…. Hauptthemen laut MEDLINE: Nanomedicine, Anti-Infective Agents. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, 'la Caixa' Foundation, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Microbial biofilms are complex three‐dimensional structures where sessile microbes are embedded in a polymeric extracellular matrix. Their resistance toward the host immune system as well as to a diverse range of antimicrobial treatments poses a serious health and development threat, being in the top 10 global public health threats declared by the World Health Organization. In an effort to combat biofilm‐related microbial infections, several strategies have been developed to independently eliminate biofilms or to complement conventional antibiotic therapies. However, their limitations leave room for other treatment alternatives, where the application of nanotechnology to biofilm eradication has gained significant relevance in recent years. Their small size, penetration efficiency, and the design flexibility that they present makes them a promising alternative for biofilm infection treatment, although they also present set‐backs. This review aims to describe the main possibilities and limitations of nanomedicine against biofilms, while covering the main aspects of biofilm formation and study, and the current therapies for biofilm treatment. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bacterial Infections and Antimicrobial Therapy Group (BIAT), Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
- Microbiology Section, Department of Genetics, Microbiology and Statistics, Faculty of Biology, University of Barcelona, Barcelona, Spain.
ORCID-Profile: Núria Blanco-Cabra, Júlia Alcàcer-Almansa, Joana Admella, Betsy Verónica Arévalo-Jaimes, Eduard Torrents
Förderung
- Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
- 'la Caixa' Foundation
- Ministerio de Ciencia e Innovación
- European Regional Development Fund (FEDER)
- Catalan Cystic Fibrosis Association
- European Union-Next Generation EU
- Generalitat de Catalunya
Zitieren
APA
Blanco-Cabra, N., Alcàcer-Almansa, J., Admella, J., Arévalo-Jaimes, B. V., & Torrents, E. (2024). Nanomedicine against biofilm infections: A roadmap of challenges and limitations. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1944
Vancouver
Blanco-Cabra N, Alcàcer-Almansa J, Admella J, Arévalo-Jaimes BV, Torrents E. Nanomedicine against biofilm infections: A roadmap of challenges and limitations. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.1944
BibTeX
@article{BlancoCabra2024,
author = {Blanco-Cabra, Núria and Alcàcer-Almansa, Júlia and Admella, Joana and Arévalo-Jaimes, Betsy Verónica and Torrents, Eduard},
title = {Nanomedicine against biofilm infections: A roadmap of challenges and limitations},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
doi = {10.1002/wnan.1944}
}
EUVIMED